Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · November 17, 2024

Efficacy and Safety of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection

Gut

 

Additional Info

Gut
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg)
Gut 2024 Nov 11;[EPub Ahead of Print], L Olmedo, X Calvet, E Gené, DS Bordin, I Voynovan, M Castro-Fernandez, M Pabón-Carrasco, A Keco-Huerga, Á Perez-Aisa, AJ Lucendo, L Rodrigo, AS Sarsenbaeva, IB Khlinov, G Fadieienko, O Zaytsev, Á Lanas, SJ Martínez-Domínguez, E Alfaro, L Jonaitis, Ó Núñez, R Pellicano, L Hernández, O Gridnyev, J Kupcinskas, A Gasbarrini, D Boltin, Y Niv, G Babayeva, R Marcos-Pinto, B Tepes, M Venerito, V Papp, F Lerang, M Leja, PS Phull, W Marlicz, M Doulberis, SM Smith, V Milivojevic, L Kunovsky, A Mestrovic, T Matysiak-Budnik, H Simsek, A Cano-Català, I Puig, L Moreira, P Parra, OP Nyssen, F Megraud, C O'Morain, JP Gisbert

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading